PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology, CTO Andrea Alesini Hospital, ASL Roma 2, Department of Systems Medicine, University of Rome \'Tor Vergata\' , Rome, Italy.\', \'UniCamillus, Saint Camillus International University of Health Sciences , Rome, Italy.\', \'Diabetes Research Institute Federation (DRIF), Department of Systems Medicine, University of Rome \'Tor Vergata\' , Rome, Italy.\', \'Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN) , Rome, Italy.\', \'Diabetes Research Institute (DRI), University of Miami Miller School of Medicine , Miami, FL, USA.\', \'Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana , Rome, Italy.\', \'Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University , Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/14787210.2020.1799785
?:doi
?:hasPublicationType
?:journal
  • Expert review of anti-infective therapy
is ?:pmid of
?:pmid
?:pmid
  • 32693652
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.264
?:rankingScore_hIndex
  • 62
?:title
  • Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all